← All articles

The Best Cognism Alternative for Healthtech Outbound in 2026

By Asaf Katz · July 24, 2026

QUICK ANSWER

Cognism is a strong B2B data provider for European compliance-sensitive markets, but healthtech outbound in the US requires depth in clinical and healthcare executive personas that Cognism's contact database underserves. Here is what healthtech vendors need from a Cognism alternative and why event-led outbound produces better healthtech pipeline.

What Is Cognism?

Cognism is a B2B sales intelligence platform headquartered in London, known primarily for its GDPR-compliant contact database with strong coverage of European and UK markets. It offers contact data, firmographic data, and intent signals for B2B outbound teams.

Cognism's strengths are its compliance framework (phone-verified mobile numbers, GDPR and CCPA compliance built in), its EMEA contact database quality, and its integration with major CRMs and sales engagement platforms. For teams doing outbound into Europe, Cognism is a legitimate top-tier choice.

For healthtech outbound teams targeting US buyers, the calculus is different.

Where Does Cognism Fall Short for Healthtech Outbound?

US healthtech contact coverage gaps. Cognism's database strength is in EMEA. US contact coverage for healthcare-specific executive personas, Chief Medical Officer, VP Clinical Operations, Head of Health Informatics, Chief Nursing Officer, and hospital system IT leadership, is meaningfully thinner than its European coverage.

Healthcare organizational complexity. Healthtech selling involves navigating hospital systems, health networks, physician practice groups, payers, and digital health startups with very different buying structures. Cognism's firmographic segmentation does not surface the organizational complexity of US healthcare systems with the same accuracy as specialized databases or enrichment stacks.

Regulatory signal data. Healthtech buyers respond to specific regulatory triggers: CMS reimbursement changes, HIPAA enforcement actions, meaningful use requirements, and value-based care contract shifts. Cognism does not provide intent or trigger data mapped to healthcare regulatory signals.

Account research depth. Selling into healthcare systems requires understanding the health network's technology partnerships, EMR systems, and clinical priorities. Cognism does not provide the account intelligence layer that healthtech outbound requires at the persona level.

What Should Healthtech Vendors Look for in a Cognism Alternative?

US healthcare contact database depth. Look for a provider with strong coverage of clinical and administrative executive personas at hospital systems, health networks, physician groups, digital health companies, and health payers. ZoomInfo has deeper US healthcare coverage than Cognism for these specific personas.

Healthcare trigger and intent signals. The best healthtech outbound is trigger-based, not cadence-based. You want a data provider or enrichment layer that surfaces regulatory changes, EMR migration announcements, new CMS contracts, and health system M&A events as outreach triggers.

HIPAA-safe data handling. Any B2B data provider you use for healthtech outbound needs to meet HIPAA-safe harbor standards for contact and account data. Verify this is documented in the provider's data processing agreements.

Clinical buyer understanding. Generic B2B data providers give you job titles. For healthtech, you need the ability to filter by clinical specialty, EMR system, health network affiliation, and Value-Based Care vs fee-for-service contract type.

Why Event-Led Outbound Works Better Than Data-Alone for Healthtech Pipeline

The fundamental problem with data-first outbound for healthtech is that clinical and administrative health system leaders are among the most outbound-fatigued buyer segments in B2B. CMOs, VPs of Clinical Operations, and health IT leaders receive enormous volumes of vendor outreach. Cold email and cold call reply rates in healthcare are consistently below 2 percent regardless of data quality.

What actually reaches healthtech buyers: peer events. Clinical and healthcare executive roundtables on specific operational or regulatory topics produce registration and attendance rates significantly above what cold sequences generate. The HIMSS conference, health system technology roundtables, and clinical operations peer discussions all draw high attendance because the peer learning value is real.

How LinkedOtter Builds Healthtech Pipeline Through Event-Led Outbound

LinkedOtter's event-led outbound motion for healthtech vendors:

  1. Identify the 200 to 400 target accounts: hospital systems, digital health companies, health networks, or payers in your ICP
  2. Build a list of the specific clinical and administrative personas at those accounts using Apollo or ZoomInfo enriched with healthcare-specific filters
  3. Design a roundtable on a specific topic those buyers are managing now: value-based care contracting challenges, EMR integration complexity, CMS regulation response, or clinical AI governance
  4. Send personalized invitations referencing the specific regulatory or operational pressure they are facing
  5. Run the event with peer discussion format, no product demo
  6. Follow up with engaged attendees within 24 hours

Results from comparable healthcare-adjacent B2B campaigns: 754 signups in 26 days from targeted invitation programs, 43 qualified meetings in 60 days from event-led follow-up. Clinical buyer events regularly produce 10 to 20 qualified attendees from 200 to 300 targeted invitations.

Cognism vs Event-Led Outbound for Healthtech: A Direct Comparison

MetricCognism cold outboundEvent-led outbound
US healthcare contact depthLimited vs ZoomInfoNot applicable (list-agnostic)
Healthcare-specific buyer triggersLimitedBuilt into event topic selection
Reply rate from healthtech personas1 to 2 percent10 to 25% event invitation acceptance
Qualified meeting cost$300 to $800$140 to $200
Buyer trust at first conversationZero (cold)Warm (attended your event)

The data alone is not the bottleneck for healthtech pipeline. The channel is.

Frequently asked questions

Why does Cognism underperform for US healthtech outbound?

Cognism's database strength is in EMEA. US coverage for healthcare-specific executive personas including CMOs, VPs of Clinical Operations, and health IT leadership is thinner than European coverage. Additionally, Cognism lacks healthcare-specific regulatory trigger signals and account intelligence for US health system complexity.

What should healthtech companies look for in a Cognism alternative?

Deep US healthcare contact coverage for clinical and administrative personas, healthcare regulatory trigger signals (CMS changes, HIPAA enforcement, EMR migrations), HIPAA-safe data handling documentation, and the ability to filter by health network affiliation and clinical specialty.

Why do healthtech buyers respond poorly to cold outbound regardless of data quality?

Clinical and administrative health system leaders are among the most outbound-fatigued buyer segments in B2B. Cold email and cold call reply rates in healthcare consistently run below 2 percent. The channel is broken for this persona group, not just the data.

How does event-led outbound compare to Cognism cold outbound for healthtech pipeline?

Event-led outbound produces 10 to 25% invitation acceptance rates vs 1 to 2% cold email reply rates for healthcare buyers, qualified meeting costs of $140 to $200 vs $300 to $800 for cold outbound, and warm buyer trust at first conversation vs zero trust from a cold-booked meeting.

Related

Take the free 60-second check